Pharmaceutical Reform

Nye, J. S., Jr. 2004. Soft Power: The Means to Success in World Politics. New York: Public Affairs. Roberts, M. J., and M. R. Reich. 2002. “Ethical Analysis in Public Health.” Lancet 359: 1055–59. Scanlon, T. M. 1998. What We Owe to Each Other. Cambridge, MA: Harvard University Press. Singer, P. 2009. The Life You Save: Acting Now to End World Poverty. New York: Random House. Stiglitz, J. E. 2002. Globalization and Its Discontents. New York: W.W. Norton.

Ethics and Priority Setting in Pharmaceutical Reform

Pharmaceutical Reform

Published on Oct 3, 2011

Medicine

World Bank Publications

About

This book applies an established analytical framework for health sector reform (Getting Health Reform Right, Oxford, 2004) to the performance problems of the pharmaceutical sector. The book is divided into three sections. The first section presents the basic ideas for analysis. It begins by insisting that reform start with a clear understanding of the performance deficiencies of the current system. Like all priority setting in the public sector, this 'definition of the problem' involves both ethical choices and political processes. Early chapters explain the foundations of these ideas and apply them to the pharmaceutical sector. The relationship of ultimate outcomes (like health status or risk protection) to classic health systems concepts like efficiency, access and quality is also explored.

Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.